Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome

Leukemia Research

Volumn 22, Issue 2, 1998, Pages 125-134

  De Souza Fernandez, Teresa ^a,b   Menezes De Souza, Jamison ^a,c   Macedo Silva, Maria Luíza ^a,b   Tabak, Daniel ^b   Abdelhay, Eliana ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti   (Brazil)

Author keywords

Chromosomal abnormalities; N ras point mutations; Primary myelodysplastic syndrome

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CHILD; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; INFANT; KARYOTYPE; MALE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; ONCOGENE N RAS; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REFRACTORY ANEMIA; SCHOOL CHILD; TRISOMY;

EID: 0032007206     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00112-4     Document Type: Article

References (34)

1. 1. Silverman, L. R., Myelodysplastic syndromes. In Cancer Medicine. Lea and Febiger, London, 1993, p. 1888.
2. 2. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C., The French-American-British (FAB) Co-operative Group. Proposals for the classification of the myelodysplastic syndrome. Br. J. Haematol., 1982, 51, 189.
3. 3. Jacobs, R. H., Cornbleet, M. A., Vardiman, J. W., Larson, R. A., Le Beau, M. M. and Rowley, J. D., Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood, 1986, 67, 1765.
4. 4. Heim, S. and Mitelman, F. (1987) Myelodysplastic syndromes. In Cancer Cytogenetics. A. R. Liss, New York, p. 111.
5. 5. Nöel, P., Tefferi, A., Pierre, R. V., Jenkins, R. B. and Dewald, G. W., Karyotypic analysis in primary myelodysplastic syndrome. Blood Reviews, 1993, 7, 10.
6. 6. Parlier, V., Melle, G. van, Beris, P.h., Schmidt, P. M., Tobler, A., Haller, E. and Jotterand-Bellomo, M., Hematological, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Cancer Genet. Cytogenet., 1994, 78, 219.
7. ras. Trends Biol. Sci., 1993, 18, 250.
8. ras activity. Trends Genet., 1991, 7, 346.
9. 9. Bar-Eli, M., Ahuja, H., Gonzales-Cadavid, N., Foti, A. and Cline, M. J., Analysis of N-ras exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing. Blood, 1989, 73, 281.
10. 10. Bartram, C. R., Molecular genetic aspects of myelodysplastic syndromes. In Hematology/Oncology Clinics of North America, ed. H. P. Koeffler. W. B. Saunders, Philadelphia, 1992, p. 557.
11. 11. Taylor, K. M., Rodwell, R. L., Taylor, D. L. and Seeley, G. O., Myelodysplasia. Current Opinion in Oncology, 1994, 6, 32.
12. 12. Oscier, D., Burnet, A. and Padua, R. A., Genetic lesions and clinical outcome in myelodysplasia (MDS). Leukemia Res., supplement, 1994, 18, 50.
13. 13. Layton, M., The molecular biology of myelodysplastic syndromes (preleukaemia). In The Myelodysplastic Syndromes, ed. G. J. Mufti and D. A. G. Galton. Churchill Livingstone, Edinburgh, 1992, pp. 151-195.
14. 14. Paquette, R. L., Landaw, E. M., Pierre, R. V., Kaham, J., Lübbert, M., Lazcano, O., Isaac, G., McCormick, F. and Koeffler, H. P., N-ras mutations are associated with poor prognoses and increased risk of leukemia in myelodysplastic syndrome. Blood, 1993, 82, 590.
15. 15. Padua, R. A., Carter, G., Hughes, D., Gow, J., Farr, C., Oscier, D., McCormick, F. and Jacobs, A., Ras mutation in myelodysplasia detected by amplification, oligonucleotide hybridization and transformation. Leukemia, 1988, 2, 503.
16. 16. Yunis, J. J., Boot, A. J. M., Mayer, M. G. and Bos, J. L., Mechanisms of ras mutations in myelodysplastic syndrome. Oncogene, 1989, 4, 609.
17. 17. Lyons, J., Janssen, J. W. G., Bartram, C., Layton, M. and Mufti, G. J., Mutations of Ki-ras and N-ras oncogenes in myelodysplastic syndromes. Blood, 1988, 71, 1707.
18. 18. Hirai, H., Kobayashi, Y., Mano, H., Hagiwara, K., Maru, Y., Omine, M., Mizoguchi, H. and Nishida, J., A point mutation at codon 13 of N-ras oncogene in myelodysplastic syndromes. Nature, 1987, 327, 430.
19. 19. Hirai, H., Okada, M., Mizoguchi, H., Mano, H., Kobayash, Y., Nishida, J. and Takaku, F., Relationship between an activated N-ras oncogene and chromosomal abnormality during leukemic progression from myelodysplastic syndromes. Blood, 1988, 71, 256.
20. 20. Tien, H. F., Wang, C. H., Chuang, S. M., Chow, J. M., Lee, F. Y., Liu, M. C., Chen, Y. C., Shen, M. C., Lin, D. T. and Lin, K. H., Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. Cancer Genet. Cytogenet., 1994, 74, 40.
21. 21. Horiike, S., Taniwaki, M., Misawa, S. and Abe, T., Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndromes and predictive value for prognosis. Cancer, 1988, 62, 1129.
22. 22. Seabright, M., A rapid banding technique for human chromosomes. Lancet, 1971, 2, 971.
23. 23. ISCN: An Inetrnational System for Human Cytogenetic Nomenclature, ed. F. Mitelman, S. Karger, Basel, 1995.
24. 24. Sambrook, J., Fritsch, E. F., Maniatis, T., Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, New York, 1989.
25. 25. Jacobs, A., Genetic abnormalities in myelodysplastic syndrome. Cancer Genet. Cytogenet., 1991, 56, 1.
26. 26. Jacobs, A., Genetic abnormalities in preleukaemia. Leukemia, 1991, 5, 277.
27. - breakpoint. Genomics, 1994, 19, 425.
28. 28. Nowell, P. C., Chromosome abnormalities in myelodysplastic syndromes. Seminars in Oncology, 1992, 19, 25.
29. 29. Stephenson, J., Lizhen, H. and Mufti, G. J., Possible coexistence of ras activation and monosomy 7 in the leukaemic transformation of myelodysplastic syndromes. Leukemia Res., 1995, 19, 741.
30. 30. Miyauchi, J., Asada, M., Sasaki, M., Tsunematsu, Y., Kojima, S. and Mizutani, S., Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood, 1994, 83, 2248.
31. 31. Neubauer, A., Greenberg, P., Negrin, R., Ginzton, N. and Liu, E., Mutations in the ras proto-oncogene in patients with myelodysplastic syndromes. Leukemia, 1994, 8, 638.
32. 32. Farr, C., Gill, R., Katz, F., Gibbons, B. and Marshall, C. J., Analysis of Ras gene mutations in childhood myeloid leukaemia. Br. J. Haematol., 1991, 77, 323.
33. 33. Abruzzese, E., Buss, D., Rainer, R., Rao, P. N. and Pettenati, M., Study of clonality in myelodysplastic syndromes: detection of trisomy 8 in bone marrow cell smears by fluorescence in situ hybridization. Leukemia Res., 1996, 20, 551.
34. 34. Janssen, J. W. G., Buschle, M., Layton, M., Drexler, H. G., Lyons, J., van den Berghe, H., Heimpel, H., Kubanek, B., Kleihauer, E., Mufti, G. J. and Bartram, C. R., Clonal analysis in myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood, 1989, 73, 248-254.